VSee Health, Inc.
VSEE
$0.37
$0.025.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 79.32% | 124.17% | 111.50% | 82.91% | 38.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.32% | 124.17% | 111.50% | 82.91% | 38.30% |
| Cost of Revenue | 187.48% | 138.71% | 152.00% | 71.74% | 19.13% |
| Gross Profit | 36.65% | 116.17% | 94.04% | 88.55% | 47.68% |
| SG&A Expenses | 111.12% | 218.12% | 187.06% | 114.85% | 27.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.76% | 201.89% | 178.14% | 103.81% | 25.56% |
| Operating Income | -347.34% | -614.65% | -541.98% | -171.26% | 7.76% |
| Income Before Tax | 79.97% | -2,143.26% | -5,507.70% | -3,113.19% | -2,124.26% |
| Income Tax Expenses | 53.50% | 127.16% | -125.12% | -128.35% | 168.86% |
| Earnings from Continuing Operations | 78.20% | -1,837.55% | -1,921.16% | -1,513.52% | -3,887.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 143.13% | 100.00% | -291.86% |
| Net Income | 78.21% | -1,811.72% | -1,874.08% | -1,497.48% | -3,865.78% |
| EBIT | -347.34% | -614.65% | -541.98% | -171.26% | 7.76% |
| EBITDA | -368.79% | -392.10% | -356.80% | -97.28% | 2.71% |
| EPS Basic | 80.43% | -997.70% | -1,071.04% | -849.45% | -1,947.57% |
| Normalized Basic EPS | -295.21% | 17.82% | -221.99% | -34.30% | 45.35% |
| EPS Diluted | 80.45% | -988.05% | -1,059.97% | -850.27% | -1,949.38% |
| Normalized Diluted EPS | -295.21% | 17.82% | -221.99% | -34.30% | 45.35% |
| Average Basic Shares Outstanding | 85.86% | 112.47% | 79.30% | 17.85% | 1.11% |
| Average Diluted Shares Outstanding | 85.86% | 112.47% | 79.30% | 17.85% | 1.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |